The panel of advisors voted 8-6 to recommend broadening BPC-157, a popular peptide
192 128, 230, 232, 235, 237, 239, 241, 243-245 Cohort sizes ranged from 4 to 40 patients (total 170)
This peptide has been studied for its potential to stimulate lipolysis, reduce fat accumulation, and improve overall body composition
Results can be positive, negative, or inconclusive, and a positive result may be confirmed with a second lab test to avoid penalties from false positives
But reactions do happen, and recognizing them early prevents unnecessary skin damage
Side Effects of DSIP DSIP is still considered an experimental peptide, and its safety profile has not been comprehensively established